Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM) - Mora-Rodriguez, Jose Maria; Sanchez, Belen G; Borta, Alicia; Diaz-Yuste, Alba; Ballester-Gonzalez, Ruben; Arrieta, Francisco; Sebastian-Martin, Alba; Diaz-Laviada, Ines (LIFE SCIENCES, 2023)